The American Journal of Surgery
Volume 199, Issue 3 , Pages 294-298 , March 2010

The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease

  • Judy Jin, M.D.

      Affiliations

    • Department of Surgery, MetroHealth Medical Center, 2500 Metrohealth Drive, Cleveland, OH 44109-1998, USA
    • ,
  • Rhoderick Machekano, Ph.D., M.P.H.

      Affiliations

    • Center for Health Care Research and Policy, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA
    • ,
  • Christopher R. McHenry, M.D.

      Affiliations

    • Department of Surgery, MetroHealth Medical Center, 2500 Metrohealth Drive, Cleveland, OH 44109-1998, USA
    • Corresponding Author InformationCorresponding author: Tel.: +1-216-778-4753; fax: +1-216-778-3774

Received 27 July 2009 ,Revised 13 August 2009

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-9610(09)00690-4

doi: 10.1016/j.amjsurg.2009.08.028

The American Journal of Surgery
Volume 199, Issue 3 , Pages 294-298 , March 2010

Article Tools

* Image Usage & Resolution